Mouse pancreatic tumor organoids reveal synergistic efficacy of low-dose anticancer drug and radiation combinations

BackgroundPancreatic cancer is the fourth-leading cause of cancer death in the United States, with a 5-year survival rate of only 13%. Most patients with locally advanced pancreatic cancer receive chemotherapy with or without radiation therapy (RT). However, current treatment approaches often result...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zachery Keepers, Aniketh Sharma, Sanjit Roy, Hurley Ryan, Binny Bhandary, Lei Ren, Narottam Lamichhane, Hem D. Shukla
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2025-09-01
Seri Bilgileri:Frontiers in Medicine
Konular:
pancreatic cancer
radiation therapy
organoid
combination therapy
5-fluorouracil (5-FU)
gemcitabine
Online Erişim:https://www.frontiersin.org/articles/10.3389/fmed.2025.1661521/full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller